164 results
Page 8 of 9
6-K
EX-99.1
emb 75eb7
26 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.2
cfc60r 2pvo6g
26 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
980wax2pyn6oje
17 Jul 14
RepliCel Appoints Brooke Hurford as Corporate Secretary and Director, Finance
12:00am
6-K
EX-99.1
lvik5mc4t3s4e1eb
23 Jun 14
RepliCel Retains O&M Partners to Coordinate North American Focused Investor Marketing Campaign
12:00am
6-K
EX-99.1
s7xerm
18 Jun 14
RepliCel Life Sciences Announces Closing of Third and Final Tranche of
12:00am
6-K
EX-99.1
50nx6dp9 69f1yk
6 Jun 14
Replicel Life Sciences Inc. 6-K
12:00am
6-K
EX-99.1
lpcd spnjjy
29 May 14
Current report (foreign)
12:00am
6-K
EX-99.2
83ftjkbbveho3d84t
29 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
pq6j7p8csyeu9l11vo
22 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
zhgnm7l558
22 May 14
Replicel Life Sciences Inc. Form 6-K
12:00am
6-K
EX-99.2
6l312zf 2v5jnm
18 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.1
boy9f73w
18 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.1
i6scg5
27 Feb 14
RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress
12:00am
6-K
EX-99.1
o7j4ejy
27 Feb 14
Replicel Life Sciences Inc. Form 6-K
12:00am
6-K
EX-99
l9n qlqdf7a
9 Jan 14
RepliCel to Commence Trading on the TSX Venture Exchange
12:00am
6-K
b36c374f pqzjrsxzww
20 Nov 13
Current report (foreign)
12:00am
6-K
EX-99.1
rljcxbkr 8509a
28 Aug 13
Current report (foreign)
12:00am
6-K
EX-99.1
orolm
12 Jul 13
Current report (foreign)
12:00am
6-K
EX-99.2
vqh3addl7sz2y49
12 Jul 13
Current report (foreign)
12:00am